0001123292-23-000059.txt : 20230516 0001123292-23-000059.hdr.sgml : 20230516 20230516090232 ACCESSION NUMBER: 0001123292-23-000059 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230516 DATE AS OF CHANGE: 20230516 EFFECTIVENESS DATE: 20230516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Athyrium Capital Management, LP CENTRAL INDEX KEY: 0001728001 IRS NUMBER: 263965190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-18509 FILM NUMBER: 23925715 BUSINESS ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-402-6925 MAIL ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR/A 1 primary_doc.xml X0202 13F-HR/A LIVE 0001728001 XXXXXXXX 03-31-2023 03-31-2023 true 1 RESTATEMENT Athyrium Capital Management, LP

505 Fifth Avenue, Floor 18 New York NY 10017

13F HOLDINGS REPORT 028-18509 000161528 801-73737 N Andrew Hyman 212-402-6925 /s/ Andrew Hyman New York NY 05-16-2023 0 8 279118575 INFORMATION TABLE 2 informationtable.xml Biora Inc. COM 74319F305 4693712 1694481 SH SOLE 1694481 0 0 Biora Inc. Note 7.250% 12/0 74319FAB3 58075575 103500000 PRN SOLE 0 0 103500000 Amryt Pharma PLC Sponsored ADS 03217L106 129138967 8857268 SH SOLE 8857268 0 0 RVL PHARMACEUTICALS PLC SHS G6S41R101 16644506 14600444 SH SOLE 14600444 0 0 Omeros Corp NOTE 6.250%11/1 682143AE2 11109890 11005000 PRN SOLE 0 0 11005000 Omeros Corp NOTE 5.250% 2/1 682143AG7 46503087 65136000 PRN SOLE 0 0 65136000 PUMA BIOTECHNOLOGY INC COM 74587V107 5537632 1792114 SH SOLE 1792114 0 0 Paratek Pharmaceuticals Inc. NOTE 4.750% 5/0 699374AB0 7415205 9000000 PRN SOLE 0 0 9000000